BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28892094)

  • 1. Deletion of Pkd1 in renal stromal cells causes defects in the renal stromal compartment and progressive cystogenesis in the kidney.
    Nie X; Arend LJ
    Lab Invest; 2017 Dec; 97(12):1427-1438. PubMed ID: 28892094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nedd9 restrains renal cystogenesis in Pkd1-/- mice.
    Nikonova AS; Plotnikova OV; Serzhanova V; Efimov A; Bogush I; Cai KQ; Hensley HH; Egleston BL; Klein-Szanto A; Seeger-Nukpezah T; Golemis EA
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12859-64. PubMed ID: 25139996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
    Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA helicase p68 inhibits the transcription and post-transcription of
    Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
    Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
    [No Abstract]   [Full Text] [Related]  

  • 6. TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease.
    Lee EJ; Seo E; Kim JW; Nam SA; Lee JY; Jun J; Oh S; Park M; Jho EH; Yoo KH; Park JH; Kim YK
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):29001-29012. PubMed ID: 33122431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. cGAS Activation Accelerates the Progression of Autosomal Dominant Polycystic Kidney Disease.
    Yoo M; Haydak JC; Azeloglu EU; Lee K; Gusella GL
    J Am Soc Nephrol; 2024 Apr; 35(4):466-482. PubMed ID: 38247039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic Mutations in Renal Cyst Epithelium in Autosomal Dominant Polycystic Kidney Disease.
    Tan AY; Zhang T; Michaeel A; Blumenfeld J; Liu G; Zhang W; Zhang Z; Zhu Y; Rennert L; Martin C; Xiang J; Salvatore SP; Robinson BD; Kapur S; Donahue S; Bobb WO; Rennert H
    J Am Soc Nephrol; 2018 Aug; 29(8):2139-2156. PubMed ID: 30042192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.
    Wang E; Hsieh-Li HM; Chiou YY; Chien YL; Ho HH; Chin HJ; Wang CK; Liang SC; Jiang ST
    J Pathol; 2010 Nov; 222(3):238-48. PubMed ID: 20814903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-Dependent Kinase 1 Activity Is a Driver of Cyst Growth in Polycystic Kidney Disease.
    Zhang C; Balbo B; Ma M; Zhao J; Tian X; Kluger Y; Somlo S
    J Am Soc Nephrol; 2021 Jan; 32(1):41-51. PubMed ID: 33046531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gα12 is required for renal cystogenesis induced by Pkd1 inactivation.
    Wu Y; Xu JX; El-Jouni W; Lu T; Li S; Wang Q; Tran M; Yu W; Wu M; Barrera IE; Bonventre JV; Zhou J; Denker BM; Kong T
    J Cell Sci; 2016 Oct; 129(19):3675-3684. PubMed ID: 27505895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
    Fitzgibbon WR; Dang Y; Bunni MA; Baicu CF; Zile MR; Mullick AE; Saigusa T
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F210-F218. PubMed ID: 29021226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.
    Hopp K; Ward CJ; Hommerding CJ; Nasr SH; Tuan HF; Gainullin VG; Rossetti S; Torres VE; Harris PC
    J Clin Invest; 2012 Nov; 122(11):4257-73. PubMed ID: 23064367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
    Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PKD1 mono-allelic knockout is sufficient to trigger renal cystogenesis in a mini-pig model.
    He J; Li Q; Fang S; Guo Y; Liu T; Ye J; Yu Z; Zhang R; Zhao Y; Hu X; Bai X; Chen X; Li N
    Int J Biol Sci; 2015; 11(4):361-9. PubMed ID: 25798056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.
    Leonhard WN; Zandbergen M; Veraar K; van den Berg S; van der Weerd L; Breuning M; de Heer E; Peters DJ
    J Am Soc Nephrol; 2015 Jun; 26(6):1322-33. PubMed ID: 25361818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney Disease.
    Weisser I; Eckberg K; D'Amico S; Buttram D; Aboudehen K
    J Am Soc Nephrol; 2024 Jan; 35(1):41-55. PubMed ID: 37953472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
    Kurbegovic A; Trudel M
    Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
    Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pkd1-targeted mutation reveals a role for the Wolffian duct in autosomal dominant polycystic kidney disease.
    Tee JB; Dnyanmote AV; Lorenzo MK; Lee OR; Grisaru S; Suk M; Acott PD
    J Dev Orig Health Dis; 2020 Feb; 11(1):78-85. PubMed ID: 31412963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.